 |
|
|
|
|
|
International Conference on Differentiation Therapy
November 11 – 14, 2009 – Chicago, IL
|
|
|
DAY 4 – November 14, 2009
|
|
|
|
|
|
8:00–8:20
|
|
Stem Cell Biology and Cancer
|
|
TBD
|
|
|
8:20–8:40
|
|
Breast Cancer Stem cells
|
|
Max S. Wicha, MD
|
|
|
8:40–9:00
|
|
Leukemia Stem Cells
|
|
Craig T. Jordan, PhD
|
|
|
9:00–9:20
|
|
Myeloma Stem Cells
|
|
William H. Matsui, MD
|
|
|
9:20–9:40
|
|
Cancer Stem Cells
|
|
Benjamin G. Neel, MD, PhD
|
|
|
9:40–10:10
|
|
Discussion
|
|
|
|
|
10:10–10:30
|
|
Break
|
|
|
|
|
|
|
|
10:30–10:50
|
|
Targeting Kinase Pathways: Is One Target Enough?
|
|
Neal Rosen, MD, PhD
|
|
|
10:50–11:10
|
|
Dasatinib and the Future of CML Therapy
|
|
Neil P. Shah, MD, PhD
|
|
|
11:10–11:30
|
|
Optimizing Combinations of FLT3 Inhibitors and Chemotherapy
|
|
Mark Levis, MD, PhD
|
|
|
11:30–11:50
|
|
Genomic Approaches to Targeted Therapy
|
|
TBD
|
|
|
11:50–12:10
|
|
Targeted Therapy of Solid Tumors
|
|
TBD
|
|
|
12:10–12:40
|
|
Discussion
|
|
|
|
|
Adjourn
|
|
|
Day 1 AgendaDay 2 AgendaDay 3 AgendaBack to Top
|
|
|
|
|
|
|
|
|
|
|
